Products for Research Use Only
RegisterLogin

COVA322

CAT: 0804-HY-P991091Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991091Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
COVA322 is a bispecific TNF and IL-17A antibody. COVA322 inhibits simultaneously TNF and the IL-17A homodimer that can be used for the study of inflammatory diseases[1].
UNSPSC
12352203
Target
Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C([A322])[V]
References & Citations
[1]Silacci M, et al. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. MAbs. 2016;8 (1) :141-9.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T9901A-817-01COVA322
GTR18679017-01COVA322 Antibody
C00907Cova322 (Anti-IL-17 & TNF-Alpha)
WA2329Research Grade Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322)
GTR18699377-01Anti-IL-17 & TNF-alpha Reference Antibody (COVA322 Biosimilar)
A137317Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322) Biosimilar (Monoclonal, IgG-VHH)

Popular Products